IX. Is it only about MYC? How to approach the diagnosis of diffuse large B‐cell lymphomas

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-1069|33|S1|50-55

ISSN： 0278-0232

Source： Hematological Oncology (Electronic), Vol.33, Iss.S1, 2015-06, pp. : 50-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel agents for diffuse large B-cell lymphoma

By Sinha Rajni   DeJoubner Nutan   Flowers Christopher  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 669-680

Informa Healthcare

Access to resources Recommend Favorite

Ophthalmoplegia with Diffuse Large B Cell Lymphoma: Vital Differential Diagnosis

By Muzammil S   Kreze OD  

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 930-932

Field House Publishing

Access to resources Recommend Favorite

Methotrexate: Diffuse large B-cell lymphoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1244, 2009-01 ,pp. : 30-31

Adis International

Access to resources Recommend Favorite

Methotrexate: Diffuse large B-cell lymphoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1180, 2007-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

Efalizumab: Diffuse large B-cell lymphoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite